Michallet, A.-S., Aktan, M., Hiddemann, W., Ilhan, O., Johansson, P., Laribi, K., Meddeb, B., Moreno, C., Raposo, J., Schuh, A., Ünal, A., Widenius, T., Bernhardt, A., Kellershohn, K., Messeri, D., Osborne, S. and Leblond, V. (2018) “Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study”, Haematologica. Pavia, Italy, 103(4), pp. 698-706. doi: 10.3324/haematol.2017.170480.